Embryo Biopsy Workshop
In collaboration with Illumina and Hamilton Thorne, the Canadian Fertility and Andrology Society (CFAS) is offering an opportunity for ART Lab Professionals to participate in a one-day embryology and hands-on embryo biopsy workshop. CFAS members have the option of attending one of two courses depending on their level of experience and proficiency. Both courses offer a balance between theory and practice.
Click to view the program!
Registration and Fees
- Registration is limited to 20 participants per course.
- Participants must qualify for the respective course they are applying to by completing a short questionnaire.
- Priority will be given to CFAS members
This event took place on September 2016
No new events are planned at this moment
|Register before August 26th||Register after August 26th|
|CFAS Members attending the annual meeting||$200||$250|
|CFAS members – embryo course only||$275||$325|
- Embryologists with limited or no experience performing embryo biopsies and cell loading techniques for the purpose of PGS/PGD testing who want to practice the technique in a controlled setting with leading experts from the field
- Previous experience performing ICSI is required
- Embryologists experienced in embryo biopsies and cell loading techniques for the purpose of PGS/PGD testing who want to extend their technical skills and theoretical knowledge.
- Experienced embryologists will have a unique opportunity to work directly with experts (and peers) to address unique challenges and questions related to embryo biopsy and PGS/PGD
- Increase your understanding in preimplantation genetics and next generation sequencing technology solutions
- Advance your skill set in trophectoderm biopsy and cell loading techniques for the purpose of PGS/PGD testing
- Collaborate with peers to enable a community that shares laboratory best practices
Morning: Introductory lectures tailored to the novice level biopsy course participant.
Afternoon: Lab practicum. Participants will perform biopsies using mice embryos.
Morning: Advanced level lectures tailored to the embryologists experienced on performing biopsies.
Afternoon: Lab practicum. Participants will perform biopsies using mice embryos.
Tuesday September 20, 2016 from 8am to 5pm
Wednesday September 21, 2016 from 8am to 5pm
The Illumina vision: Illumina is a global company with a vision to be the leading provider of integrated solutions that advance the understanding of genetics and health. Our goal is to improve human health by unlocking the power of the genome.
Leading-edge products and services: Illumina has developed a comprehensive line of products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. Our broad portfolio of leading-edge sequencing and array-based solutions address a range of genomic complexity and throughput, enabling researchers to select the best solution for their scientific challenge.
The Company’s novel laser systems are a standard in IVF clinics and are rapidly emerging as the dominant products to facilitate precise micro-surgical procedures with stem cells and other living cells in the laboratory. Specific applications include the reducing time in developing transgenic animal models, dramatic reductions in cell damage during micro-surgical procedures and higher yields for many cell procedures.
Hamilton Thorne’s CASA (Computer Assisted Sperm Analysis) image analysis systems are designed to bring quality, efficiency and reliability to studies of reproductive cells in the human fertility, animal sciences and reproductive toxicology fields. These systems assist researchers and clinicians in analyzing sperm motility and other characteristics in human fertility, toxicology and animal applications.
Ms. Ketterson currently serves as the Vice President of Operations for Reprogenetics. Ms. Ketterson has worked with Reprogenetics since its incorporation and became a part of the management team in August of 2004. She is also a co-founder of Recombine and Althea Science. Ms. Ketterson was instrumental in the recent acquisitions of Reprogenetics and Recombine companies by CooperSurgical. and Althea Science. Ms. Ketterson completed the Masters Program in Biomedical Science at the Jones Institute at Eastern Virginia Medical School in Norfolk, Virginia.
Ms. Ketterson is also a highly experienced clinical embryologist specializing in embryo biopsy techniques. She worked under the direction of Dr. Jacques Cohen from 1996-2004 at The Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center performing routine IVF procedures, clinical research trials and as the Executive Director for several educational conferences specializing in the continuing education of reproductive endocrinologists, IVF nurses, embryologists, andrologists and administrative staff.Prior to her career in reproductive woman’s health, Ms. Ketterson worked for six years as a health care consultant for Buck Consultants, Inc.
Jason E. Swain, PhD, HCLD is the Corporate Laboratory Director of the CCRM IVF Laboratory Network, overseeing a growing network of 9 clinical IVF laboratories in North America. Dr. Swain is responsible for laboratory design, protocol/procedure implementation, as well as staff training and ongoing quality control monitoring for the network embryology, andrology and endocrinology laboratories. He is also an Adjunct Clinical Associate Professor in Obstetrics and Gynecology at Rutgers University as well as at the University of Minnesota. Jason completed his BSc at Hillsdale College in his native Michigan, his MSc in Animal Science at Purdue University, his PhD in Molecular & Integrative Physiology at the University of Michigan. Dr. Swain has published more than 38 peer-reviewed articles, authored several book chapters and contributed to various other publications within the field of assisted reproduction. His primary research interests include pursuit of methods to improve in vitro embryo culture conditions through reduction of environmental stressors via modification of both the physical and chemical culture environment. Dr. Swain has given numerous regional, national and international invited lectures on various topics related to the IVF laboratory. He is the Editor-in-Chief of the Journal for Clinical Embryology, Associate Editor for the Journal of Assisted Reproduction and Genetics, sits on the editorial board for 6 journals and acts an ad hoc reviewer for 19 others. Jason is an active member within ASRM, ESHRE and the AAB.
()Dr. Charles Bormann is the Director of the ART Laboratory at Massachusetts General Hospital in Boston, Massachusetts and Instructor of Obstetrics and Gynecology at Harvard Medical School. Having graduated with a Bachelor of Science in Animal Science at Iowa State University, he received a M.S. in Reproductive Physiology from Purdue University and a Ph.D. in Reproductive Physiology from the University of Connecticut and then undertook his post-doctoral fellowship at the University of Michigan.
Dr. Bormann’s research interests include investigating the effects of maternal and environmental factors on sperm, oocyte and embryo quality and developing non-invasive methodologies for assessing human embryo developmental competency. Dr. Bormann has been an invited speaker at several regional and national ART meetings. He has authored numerous peer-reviewed papers on various aspects of mammalian gamete and embryo physiology. Dr. Bormann is the past-president of the Society for Reproductive Biologists and Technologist (SRBT) and he currently serves as the Chair of the IVF Laboratory Director Committee for the Society for Assisted Reproductive Technology (SART) and as the Chair for the Membership and Credentialing Committee for the College of Reproductive Biologists (CRB).
In addition to her independent consulting roles, Catherine is Director of West Coast Client Services and Sales for Reprogenetics, the market leader in Preimplantation Genetic Screening and Diagnosis and Senior Territory Manager for the IVF Business Unit for Recombine. She has participated as an instructor for many of Illumina’s biopsy workshop and has a passion for collaboration in sharing and learning best practices in the embryology field. Catherine lives in Southern California with her husband and four children.
()Currently, Tyl works for Illumina as a Market Development Manager. Tyl is also pursuing his doctorate in genetics at the University of Kent in England under Professor Darren Griffin, Ph.D. in conjunction with Susan Gitlin, Ph.D. at the Eastern Virginia Medical School.
In terms of embryology, he was trained at Reproductive Biology Associates in Atlanta, Georgia. He then moved to Main Line Fertility and Reproductive Medicine outside of Philadelphia where he started the PGS and oocyte vitrification program.
While there Tyl was selected by Reprogenetics and Drs. Munne and Wells to become the first center in the United States to have a live birth from a blastocyst screened with NGS. Tyl and his family live in Charlotte, North Carolina. On weekends, he can be found in the Appalachian foothills, supporting his unhealthy obsession with fly fishing.